Dimension scores are derived from public data and fields; weighted into the composite. Reference only.
Polymer Conversions (PCI) is a medical injection molding and full-service contract manufacturer based in Orchard Park, New York, USA, founded in 1979. According to the website, it focuses on manufacturing thermoplastic products for the medical device, life sciences, pharmaceutical, biomedical, veterinary, and dental industries. The site also notes that “PCI is now Medbio, Orchard Park,” suggesting that the brand or business entity may have been integrated into or transitioned under the Medbio organization.
This is not a SaaS or enterprise software product, but a manufacturing service provider. Its core capabilities include precision medical injection molding, engineering support, mold design/manufacturing/transfer, Class 7 and Class 8 cleanroom manufacturing, assembly, decorating, packaging, and other value-added services. Its production system emphasizes scientific molding, real-time data collection, SPC process monitoring, batch traceability, and automatic segregation of nonconforming products. The company operates more than 25 injection molding machines ranging from 28 to 390 tons and is equipped with three-axis servo robots.
PCI states that it is FDA-registered, with a quality management system certified to ISO 13485 and ISO 9001, and that it operates in accordance with FDA 21 CFR Part 820 medical device quality system regulations and cGMP. Process and SPC data are securely stored and continuously backed up, and the company also mentions having formal disaster recovery and contingency plans. This information is particularly important for medical OEM customers.
The website does not disclose standard pricing, packages, or an online ordering process. Given the nature of its business, pricing is typically project-based and depends on mold complexity, materials, cleanroom classification, validation requirements, assembly and packaging needs, and production volume.
Its strengths include long-standing experience in medical manufacturing, in-house coverage of tooling, engineering, injection molding, and post-processing, as well as a comprehensive quality system, making it suitable for projects requiring high precision and strong traceability. Its drawbacks are that it is not a software product and provides no information on APIs, third-party integrations, permission management, or cloud deployment; pricing, lead times, and cross-border service details are also not publicly disclosed.
It is best suited for medical device OEMs or life sciences companies seeking a compliant U.S.-based injection molding and contract manufacturing partner. Access from China cannot be determined from the available content. For Chinese companies considering cooperation, it would be especially important to evaluate cross-border communication, sample shipping, regulatory documentation, logistics, and overall cost.
⚠ This review is compiled from public sources and does not constitute a purchase recommendation. Verify all facts on the vendor's official site. Verify on polymerconversions.com official site.
polymerconversions.com is an United States Health provider. TG4G tracks its product information, an overall rating of 6.0/10, and a China-accessibility score of Limited (proxy recommended). Click "Visit Official Site" to reach polymerconversions.com directly.